Life Technologies Received IR Global Rankings Honors

Life Technologies was awarded “Best Corporate Governance in the Health Care Industry” and rated among the “Top 5 Corporate Governance in North America” for 2010, as announced by Investor Relations Global Rankings (IRGR) on April 6. IRGR is the most comprehensive auditing and ranking system for investor relations websites, corporate governance practices and financial disclosure procedures.

More than 500 companies from over 30 countries were evaluated, and Life Technologies was ranked against 53 others in our area. The award takes into consideration remuneration and performance, board accountability, capital structure, shareholder protection, shareholder meetings, internal control mechanisms, financial statements and disclosure.

Life Technologies Highlights Genomic Analysis Technologies at 101st Annual Meeting of the American Association For Cancer Research

WASHINGTON, DC, April 16, 2010 – Life Technologies’ genomic sequencing and analysis products and a number of presentations specific to oncology research, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting is taking place Saturday, April 17 through Wednesday, April 21 at the Walter E. Washington Convention Center in Washington, DC.

During the AACR conference, Life Technologies will emphasize its commitment to cancer research with multiple presentations, including the commercial release of the research-use-only (RUO) KRAS and BRAF Mutation Analysis Reagents under the Life Technologies brand, Applied Biosystems®. The reagent sets can be analyzed using the 3500 Series Genetic Analyzer.

Work conducted by a team led by Howard Doong, Ph.D, of TrimGen Corporation will present results of Life Technologies’ new KRAF and BRAF mutation analysis reagent sets at a late-breaker poster session on Tuesday, April 20 from 9 a.m. to noon. Using these reagent sets for KRAS analysis, Dr. Doong will report on his study comparing KRAS mutations observed in 118 formalin-fixed paraffin-embedded tumor samples. Mutations in KRAS and BRAF oncogenes have been implicated to have an association with certain cancer treatments.

In addition, several abstracts and papers using the SOLiD 4 System will be presented at the meeting, including a presentation by Dr. Victor E. Velculescu of The Johns Hopkins Oncology Center. Dr. Velculescu is using the system to identify personalized biomarkers for solid tumors.

This approach may one day provide broadly applicable improvements to the clinical management of cancer patients. The high accuracy of the SOLiD 4 System is critical in discovery of rare variants in heterogeneous tumor samples.

Life Technologies’ at AACR Breakout Sessions

AACR presentations demonstrate the broad utility, superior accuracy and reliability of Life Technologies’ tools across multiple generations of genetic sequencing and analysis technology – qualities that are important to oncology research from discovery to the clinic. These presentations include:


Saturday, April 17
• Conference Session #MW12: “Next-Generation Sequencing: Data Analysis and Applications”
3:15 p.m. – 5:15 p.m., Room 145
Chairperson: Dr. Victor Velculescu, John Hopkins Oncology Center
• Conference Session #MW12: “SOLiD Sequencing With Error Correction Codes: In Pursuit of Somatic Mutation Detection”
3:45 p.m. – 4:05 p.m., Room 145
Presenter: Kevin McKernan, Life Technologies

Monday, April 19
• Poster # 2212/1: “A Genomic Portrait of Tumor Progression Using Next Generation Sequencing”
2:00 p.m. – 5:00 p.m., Exhibit Hall A-C, Poster Section 10
Presenter: Dr. Jun S. Wei, National Cancer Institute
• Presentation #2196: “Genome-Wide Analysis of DNA Methylation Patterns in Formaldehyde-Fixed Paraffin-Embedded (FFPE) Human Tumor Specimens”
2:00 p.m. – 5:00 p.m., Exhibit Hall A-C, Poster Section 9, Board #15
Presenter: Dr. Fabienne Brenet, Weill-Cornell College

Tuesday, April 20
• Presentation #2957: “Characterization of Oral Tumors by Massively Parallel Litgation Sequencing”
9:00 a.m. – Noon, Exhibit Hall A-C, Poster Section 1, Board #18
Presenter: Dr. Rebecca R. Laborde, Mayo Clinic
• Poster # 2117/8: “Identification of Rare KRAS Mutations in Codons 12 and 13 by Shifted Termination Assay,” Late-Breaking Research: Clinical Research 2.
9.00 am – Noon, Exhibit Hall A-C, Poster Section 40. Abstract number: LB-222.
Presenter: Julian Walker, Life Technologies

For more information on our technologies, please stop by our booth #534.

About Life Technologies (www.lifetechnologies.com)
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit us online at www.lifetechnologies.com. Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

For Research Use Only. Not for use in diagnostic procedures.

Life Technologies Contact
Patty Zamora
760.476.7818
patty.zamora@lifetech.com
or
Heather Platisha
415.637.8025
heather.platisha@edelman.com

Science in the Classroom

Mother Teresa Catholic Elementary School is proud to announce the donation of a 310 DNA Analyzer by Life Technologies Corporation, which will be used in the school’s science laboratory.

The analyzer was donated to the school by Life Technologies, at the request of MTCES parent Gregory LaCrosse, a regional specialist in Molecular Biology for the company. LaCrosse sought the donation as part of an effort to encourage and foster interest in science at the grade school level.

“As educators, we are always looking for new ways to encourage and excite children academically,” remarked Sister Anne, MTCES Principal. “Greg LaCrosse and his wife Julie are among a group of parents working to show students how science plays an important role in everyday life. The addition of the DNA Analyzer to our science lab, coupled with the innovative programs and presentations planned by our parents and teachers, will have a long-term positive impact on our students.”

LaCrosse added, “We hope to get other schools to visit and use our lab. My long term hope is that this idea spreads to other dioceses and districts, resulting in more people becoming interested in science.”

Mother Teresa Elementary School, an independent Catholic school serving families of kindergarten through eighth grade children, is located at 7197 Mother Teresa Lane (formerly 6085 Jackie Drive) in Liberty Township.

Making Cells to Grow Sales - Expanding the GIBCO Footprint

While GIBCO has been known for almost 50 years as an industry leader for cell culture media, the move upstream into the creation of recombinant CHO cell lines is a more recent shift in product strategy. Beginning in 2009 with the launch of Life Technologies first integrated cell line kit (OptiCHO Protein Express), the strategy of creating platforms for biotherapeutic production has become a focus for the Grand Island, Bedford, and Frederick R&D teams. In line with this expanded R&D mission, we are excited to announce that Dr. Shue-Yuan Wang has joined the R&D team as the Director of Cell Line Development with responsibility for mammalian cell line products and services designed for biotherapeutic production. Shue has established a reputation as a thought leader in industrial cell culture and brings significant industry knowledge in therapeutic development through prior roles at Johnson and Johnson, Amgen, Abbott, and Human Genome Sciences. With multiple new kit launches scheduled over the next several years, this focus on industry leading platforms for biotherapeutics will expand GIBCO's future beyond our traditional cell culture media roots.

Win a Countess Automated Cell Counter for your lab!

To celebrate the success of the Countess® Automated Cell Counter, we are giving away a Countess®, a 16GB iPad with Wi-Fi and a Nintendo Wii 4 in 1 Sport Kit Bundle. Learn more about the contest and how to win any of the prizes by entering the Countess® video contest.

The Countess Automated Cell Counter take the subjectivity and tedium out of one of the fundamental steps of cell culture - counting live and dead cells. With the Countess Automated Cell Counter, producing quality reproducible data is fast and easy. It is also affordable and small, and can easily fit into a lab's budget and workspace. Click here to learn more about the Countess and how it can work for your lab.

No purchase necessary. Submission deadline is May 31, 2010, 11:59 pm PDT. The contest requires min. of 5 video submissions from different entrants. And to win, each submission must receive min. of 500 votes. The complete official rules of entry can be found here after clicking the "enter" tab.

Life Technologies Japan Completes Installation of Japan National Police Agency's 3B Yen Investment to Upgrade Forensic Testing Instrumentation

TOKYO, Japan – March 25, 2010 – Life Technologies Japan, a subsidiary of Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced that it has completed the installation of DNA analysis software, genetic analyzers, and DNA extraction instrumentation for the National Police Agency (NPA) and its 47 prefectural forensic science laboratories. This installation represents a 3 billion yen (approximately $30M) investment by the NPA to modernize its testing systems in all prefectural police agencies across Japan, and increases their current capabilities to enable high throughput forensic testing. NPA chose Life Technologies’ forensic testing instrumentation because it meets the rigorous requirements to provide the highest quality testing results to law enforcement officers.

“Japan’s recent investment demonstrates a strong commitment to protecting public safety and establishes Japan’s prefectural forensic science laboratories as one of the world’s most sophisticated laboratory systems,” said Leonard Klevan, Ph.D., President of Human Identification at Life Technologies. “This commitment is part of a larger trend in the United States, Europe, China and other countries to utilize the power of DNA databases to share investigative information in order to enhance the criminal process and bring justice to victims worldwide.”

Japan transitioned to a mixed jury system for serious crimes in 2009. This change in the legal system created a need to evaluate a broader scope of evidence and is expected to increase the overall use of DNA in the investigative and legal process. “We expect that the enhanced capacity will accommodate this increasing need for more DNA analysis,” said Siddhartha Kadia, PhD., Chief Operating Officer of Life Technologies Japan. “Life Technologies has been providing leading edge DNA analysis instrumentations for Japan’s police system since the 1990’s. We are committed to ensuring that the latest instrumentation is utilized effectively to provide the highest quality testing results to law enforcement officers. We value the trust that the NRIPS and NPA have in Life Technologies, and will provide our best support as Japan transitions into a new legal system.”

About Life Technologies (www.lifetechnologies.com)

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com. Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

About Life Technologies Japan (http://www.lifetech.co.jp/)

Life Technologies Japan is a subsidiary of Life Technologies Corporation. Life Technologies brands are found in more than 90 percent of research laboratories in Japan. The company serves more than 55,000 end-users in Japan, including leading scientists in both academic and commercial life science and biotechnology organizations. Life Technologies Japan employs approximately 350 people.

Safe Harbor Statement

This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

For Research Use Only. Not for use in diagnostic procedures.

Life Technologies Japan Contact

Eriko Takahata

+81 30 5566 6563

Eriko.Takahata@lifetech.com

Excite Your Mind!

The 2010 San Diego Science Festival Expo is tomorrow, Saturday, March 27 at Petco Park. Admission is free and there will be 150 hands-on exhibits and 20 stage performances. Visit the Life Technologies Discovery Stage from 10:30 - 3:30PM where kids can touch science. It's fun for the whole family!

Get the full schedule here.